» Articles » PMID: 26843919

Successful Living Donor Intestinal Transplantation in Cross-match Positive Recipients: Initial Experience

Overview
Specialty Gastroenterology
Date 2016 Feb 5
PMID 26843919
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Sensitized patients tend to have longer waiting times on the deceased donor list and are at increased risk of graft loss from acute or chronic rejection compared to non-sensitized candidates. Desensitization protocols are utilized to decrease the levels of alloantibodies and to convert an initial positive cross-match to prospective donors into a negative crossmatch. These procedures are mostly available in the setting of living donation. Due to the elective nature of the procedure, desensitization protocols can be extended until the desire result is obtained prior to transplantation. We present two cases of successful desensitization protocol applied to living donor intestinal transplant candidates that converted to negative cross-match to their donors. We present two cases of intestinal transplant candidates with a potential living donor to whom they are sensitized. Both cases underwent successful transplantation after desensitization protocol. No evidence of humoral rejection has occurred in either recipient. Living donor intestinal transplantation in sensitized recipients against the prospective donors provides the ability to implement a desensitization protocol to convert to negative cross-match.

Citing Articles

Chimerism-Mediated Tolerance in Intestinal Transplantation.

Crosby K, Long K, Fu J Gastroenterol Clin North Am. 2024; 53(3):413-430.

PMID: 39068003 PMC: 11284277. DOI: 10.1016/j.gtc.2023.12.009.


Outcome After Intestinal Transplantation From Living Versus Deceased Donors: A Propensity-matched Cohort Analysis of the International Intestinal Transplant Registry.

Ceulemans L, Dubois A, Clarysse M, Canovai E, Venick R, Mazariegos G Ann Surg. 2023; 278(5):807-814.

PMID: 37497671 PMC: 10549910. DOI: 10.1097/SLA.0000000000006045.


Duodenocolostomy as Treatment of Ileus in Short Bowel Syndrome: A Case Report.

Stamopoulos P, Viebahn R, Schenker P Am J Case Rep. 2018; 19:796-799.

PMID: 29976919 PMC: 6066967. DOI: 10.12659/AJCR.909003.


Updates on antibody-mediated rejection in intestinal transplantation.

Wu G World J Transplant. 2016; 6(3):564-72.

PMID: 27683635 PMC: 5036126. DOI: 10.5500/wjt.v6.i3.564.


Management and Complications of Short Bowel Syndrome: an Updated Review.

Carroll R, Benedetti E, Schowalter J, Buchman A Curr Gastroenterol Rep. 2016; 18(7):40.

PMID: 27324885 DOI: 10.1007/s11894-016-0511-3.

References
1.
Abu-Elmagd K, Costa G, Bond G, Soltys K, Sindhi R, Wu T . Five hundred intestinal and multivisceral transplantations at a single center: major advances with new challenges. Ann Surg. 2009; 250(4):567-81. DOI: 10.1097/SLA.0b013e3181b67725. View

2.
Gondolesi G, Blondeau B, Maurette R, Hoppenhauer L, Rodriguez-Laiz G, Schiano T . Pretransplant immunomodulation of highly sensitized small bowel transplant candidates with intravenous immune globulin. Transplantation. 2006; 81(12):1743-6. DOI: 10.1097/01.tp.0000226078.94635.76. View

3.
Testa G, Panaro F, Schena S, Holterman M, Abcarian H, Benedetti E . Living related small bowel transplantation: donor surgical technique. Ann Surg. 2004; 240(5):779-84. PMC: 1356482. DOI: 10.1097/01.sla.0000143266.59408.d7. View

4.
Bond G, Reyes J, Mazariegos G, Wu T, Schaefer N, Demetris J . The impact of positive T-cell lymphocytotoxic crossmatch on intestinal allograft rejection and survival. Transplant Proc. 2000; 32(6):1197-8. PMC: 3005342. DOI: 10.1016/s0041-1345(00)01181-7. View

5.
Iyer H, Jackson A, Zachary A, Montgomery R . Transplanting the highly sensitized patient: trials and tribulations. Curr Opin Nephrol Hypertens. 2013; 22(6):681-8. DOI: 10.1097/MNH.0b013e328365b3b9. View